Khamenei’s statement reflects decades of tense relations between Iran and the West which have not abated in the waning days of Donald Trump’s presidency File photo of Ayatollah Ali Khamanei. …
vaccines
-
-
Supreme Leader Ayatollah Ali Khamenei Friday banned Iran from importing of American Pfizer-BioNTech and Britain’s Astrazeneca Covid-19 vaccines, a reflection of mistrust toward the West. In a televised speech, he …
- Science
India to play vital role in equitable distribution of COVID-19 vaccines around the world: Pharma industry
With vaccine rollout beginning in some countries, the world ravaged by the COVID-19 pandemic is looking to India for the large-scale production and supply of coronavirus vaccines as it enters …
-
Ecuador’s ambassador to India Hector Cueva Jacome has expressed his confidence in Indian COVID vaccines, highlighting that are ‘part of the solution’. He himself was part of phase-3 trials of …
-
South Africa will be receiving 1.5 million doses of vaccine from Serum Institute of India (SII), country’s health minister, Dr Zweli Mkhize said in a statement. “Today, I am pleased …
-
FORT LAUDERDALE, Fla. (AP) — Florida launched an investigation Wednesday into an upscale nursing home amid reports that it administered coronavirus vaccines to wealthy donors and members of a country …
- News
All Indian vaccines being developed for storage at 2-8 degree Celsius, says DBT Secy – India News , Firstpost
Unlike the Pfizer and Moderna which requires a minus 70 degree Celsius (cold) chain, most Indian vaccine candidates have been designed to work at storage temperatures of 2-8 degrees Celsius …
-
There are some concerns with such systems, however. Residents who are used to booking tickets for shows through online platforms may find it easier to lock in a vaccination time …
-
Serum Institute of India CEO Adar Poonawalla and Bharat Biotech managing director Dr Krishna Ella have in a joint statement Tuesday said that it was their combined intent to develop, …
- News
SII, Bharat Biotech engage in war of words: A look at controversies surrounding vaccines cleared by DCGI – Health News , Firstpost
The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India took place after the DCGI announced the approval of the Covaxin and Covishield vaccines Representational image. …
-
More than two-thirds of the 15 million coronavirus vaccines shipped within the United States have so far gone unused, US health officials said on Monday, as the governors of New …
-
The number of samples detected with the the new, more contagious strain of the novel coronavirus — the UK “variant under investigation” VUI-202012/01 — is now 38, the government said …
-
NEW YORK:More than two-thirds of the 15 million vaccines shipped within the United States have so far gone unused, U.S. health officials said on Monday, as the governors of New …
- News
Coronavirus LIVE Updates: India Set for Inoculation Drive After Go-Ahead to 2 Covid-19 Vaccines; UK Sees Tougher Rules as Cases Surge
The approval came amid fear in India, as in other countries, about the safety of the shots. A recent survey of 18,000 people across India found that 69 percent were …
-
The U.S. Centers for Disease Control and Prevention said it had administered 4,225,756 first doses of COVID-19 vaccines in the country as of Saturday morning and distributed 13,071,925 doses. The …
-
Due to resilience developed by people owing to their young age, persuading them about the virus is quite a task. As richer countries race to distribute COVID-19 vaccines, Somalia remains …
- News
Coronavirus LIVE Updates: Harsh Vardhan Hails ‘Watershed Moment’; Vaccines 110% Safe, Says DCGI
The regulator is likely to approve administering two doses of the AstraZeneca-Oxford vaccine and Covaxin, the locally developed one by Bharat Biotech, each four weeks apart, a Reuters report said …
-
India’s drugs regulator has given final emergency-use approval for two coronavirus vaccines — Serum Institute of India’s Covishield, developed by Oxford University and pharma major AstraZeneca, and Bharat Biotech’s Covaxin. …
-
India has authorised the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University and by local pharmaceutical firm Bharat Biotech, the country’s drug regulator said Sunday. (Representational …
-
After the Drug Controller General of India (DCGI) on Sunday approved the emergency use of both Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin for immunisation against Covid-19 in India, Prime Minister …
- News
Covid vaccines don’t belong to any political party, but humanity: Omar Abdullah on Akhilesh’s remark
COVID-19 vaccines do not belong to any political party, but humanity, National Conference leader Omar Abdullah said on Saturday, hours after Samajwadi Party chief Akhilesh Yadav termed coronavirus vaccines to …
-
The Indian government has granted an in-principle approval for two vaccines against Coronavirus, setting the stage for the roll out of the first phase of mass vaccination in the country. …
- News
As more COVID-19 vaccines get approval, experts debate if it’s time for trial volunteers to get the real thing – Health News , Firstpost
In an ideal world, vaccine trial participants could hold off to discover whether they received the dummy shot or the vaccine. But experts agree the current circumstances are extraordinary Tens …
-
In a bid to build trust and enable confidence in the Covid-19 vaccine amongst people, the Union Health Ministry will rope in celebrities, faith leaders, media, and RWAs to disseminate …
-
India which has consolidated its position as the “pharmacy of the world” amid covid crisis has sent the Maldives 2400 vials of BCG vaccine. The dispatched supply of vaccines that …
-
India which has consolidated its position as the ‘pharmacy of the world’ amid COVID-19 crisis by sending the Maldives 2400 vials of BCG vaccine. The dispatched supply of vaccines that …